Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar brenoboyle (71.08) Submitted: 1/28/2013 11:22:41 PM : Outperform Start Price: $84.87 AMGN Score: +19.03

Massive buyback, impressive pipeline and possible biosimilar play with Watson. Low beta, fair valuation and biotech is hot.

Featured Broker Partners


Advertisement